Search





Search





Markets
/
Stocks
/
cadl
/

Candel Therapeutics Inc

CADL

Add to Watchlist

9.560USD

-0.300-3.04%

Close 07-24 16:00（ET）Quotes delayed by 15 min

524.83MMarket Cap

LossP/E TTM

Candel Therapeutics Inc

9.560

-0.300-3.04%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-24

Previous score

3.00

Change

The current institutional shareholding score of Candel Therapeutics Inc is 3.00, ranking 192 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 33.26%, representing a quarter-over-quarter decrease of 33.22%. The largest institutional shareholder is Steven Cohen, holding a total of 65.26K shares, representing 0.15% of shares outstanding, with 2.53% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

8.23M

+0.01%

Manning (Paul B.)

4.44M

+57.42%

BlackRock Institutional Trust Company, N.A.

2.60M

+19.97%

Acorn Capital Advisors, LLC

2.58M

Aguilar-Cordova (Estuardo)

2.42M

+8.57%

Aguilar (Laura K)

2.36M

-22.65%

Portolan Capital Management, L.L.C.

1.70M

+22.49%

BKB Growth Investments LLC

1.30M

Geode Capital Management, L.L.C.

977.51K

+5.31%